About

About Cantargia Strategy Business development Management Board of Directors Careers

Research & development

Scientific background Scientific concept Our therapeutic areas Our clinical trials Our patents Publications and scientific presentations

Pipeline

Investor relations

Share information Analyst coverage Financial reports Financial calendar Event calendar Corporate governance General meetings Rights issue

Newsroom

News and press releases Analyses and presentations Subscribe Media contact Media library

Contact



Press release

Dec 21, 2017 · Regulatory information

Cantargia is provided with SEK 232 million following completed share issues

Read the press release here: https://cantargia.com/en/investors/shareoffering

CONTACT US
Cantargia AB
Scheelevägen 27
SE-223 63 Lund, Sweden

E-mail: info@cantargia.com
Switch board: +46(0)46 2756260

Privacy Policy

Subscribe to our press releases

© Copyright 2024 · Cantargia AB